Drug Database
Back to search

Poland· PL-100535756

Cartexan

A chondroitin sulfate product containing chondroitini natrii sulfas, registered in Poland by Allpharm Sp. z o.o. sp.k.. The same ATC class is registered in 5 of our 19 countries.

ATC M01AX25

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCartexanATCM01AX25REGISTER NO.PL-100535756PACKS LISTED3CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about chondroitini natrii sulfasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Chondroitin sulfate is registered in 5 of 19 countries.

Countries holding a registration under ATC M01AX25 (chondroitin sulfate), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 4 of them publish a price we can compare per daily dose
Search chondroitin sulfate products by name

Chondroitin sulfate · ATC M01AX25

5 / 19 countries

  • Czechiaprice
  • Finlandprice
  • Japan
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Chondroitini natrii sulfas
Manufacturer
Allpharm Sp. z o.o. sp.k.
Country
Poland (PL)
ATC code
M01AX25
ATC class
Chondroitin sulfate
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 3

  • gtin
    05909991598563
  • gtin
    05909991598570
  • gtin
    05909991598556

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

3 interactions on record for chondroitin sulfate.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check chondroitin sulfate against other medicinesHow interaction checks work

Chondroitin sulfate · interactions on record

3 records

  • 2 moderate

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Chondroitin sulfate in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All chondroitin sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 20 EEA countries. Names it is sold under:

  • Austria · Cartexan, Condrosulf
  • Belgium · Hirudoid
  • Czechia · Condrodin, Condrosulf
  • Germany · Hirudoid, Hirudoid Forte
  • Denmark · Hirudoid
  • Spain · Condrodin, Condroitín Sulfato Kern Pharma
  • Finland · Cartexan, Cartexan Laboratorio Reig Jofre, S.A.
  • France · Chondrosulf, Chondrosulf Sans Sucre Édulcoré Au Xylitol
  • United Kingdom (Northern Ireland) · Hirudoid, Hirudoid Gel
  • Greece · Condromed
  • Hungary · Cartexan, Condrosulf
  • Iceland · Hirudoid
  • Italy · Condral, Condrosulf
  • Luxembourg · Hirudoid
  • Netherlands · Hirudoid
  • Norway · Hirudoid
  • Portugal · Hirudoid, Ossin
  • Romania · Hirudoid
  • Sweden · Hirudoid
  • Slovakia · Condrosulf, Hirudoid Forte

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/c94e8a2d-c557-42fc-95b5-cc7bfc95e55b
GET /v1/drugs/c94e8a2d-c557-42fc-95b5-cc7bfc95e55b?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Kapsułki twarde",
  "source": "urpl",
  "strength": "400 mg",
  "packaging": "05909991598556 ¦ Rp ¦ 166580\n24 szt.\n05909991598563 ¦ Rp ¦ 166581\n60 szt.\n05909991598570 ¦ Rp ¦ 166582\n180 szt.",
  "substance": "Chondroitini natrii sulfas/400 mg",
  "common_name": "Chondroitini natrii sulfas",
  "pl_product_id": "100535756",
  "pozwolenie_nr": "130/26",
  "auth_procedure": "IR",
  "authorisation_validity": "2031-04-10"
}
API referenceMCP serverPlans

See everything about chondroitin sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console